1. Home
  2. FBIOP vs NMG Comparison

FBIOP vs NMG Comparison

Compare FBIOP & NMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIOP
  • NMG
  • Stock Information
  • Founded
  • FBIOP N/A
  • NMG 2011
  • Country
  • FBIOP United States
  • NMG Canada
  • Employees
  • FBIOP 101
  • NMG N/A
  • Industry
  • FBIOP Biotechnology: Pharmaceutical Preparations
  • NMG Other Metals and Minerals
  • Sector
  • FBIOP Health Care
  • NMG Basic Materials
  • Exchange
  • FBIOP Nasdaq
  • NMG Nasdaq
  • Market Cap
  • FBIOP N/A
  • NMG N/A
  • IPO Year
  • FBIOP N/A
  • NMG 2017
  • Fundamental
  • Price
  • FBIOP $6.74
  • NMG $1.82
  • Analyst Decision
  • FBIOP
  • NMG Strong Buy
  • Analyst Count
  • FBIOP 0
  • NMG 2
  • Target Price
  • FBIOP N/A
  • NMG $2.58
  • AVG Volume (30 Days)
  • FBIOP N/A
  • NMG 94.3K
  • Earning Date
  • FBIOP N/A
  • NMG 05-13-2025
  • Dividend Yield
  • FBIOP N/A
  • NMG N/A
  • EPS Growth
  • FBIOP N/A
  • NMG N/A
  • EPS
  • FBIOP N/A
  • NMG N/A
  • Revenue
  • FBIOP N/A
  • NMG N/A
  • Revenue This Year
  • FBIOP N/A
  • NMG N/A
  • Revenue Next Year
  • FBIOP N/A
  • NMG N/A
  • P/E Ratio
  • FBIOP N/A
  • NMG N/A
  • Revenue Growth
  • FBIOP N/A
  • NMG N/A
  • 52 Week Low
  • FBIOP N/A
  • NMG $1.22
  • 52 Week High
  • FBIOP N/A
  • NMG $2.58
  • Technical
  • Relative Strength Index (RSI)
  • FBIOP 67.87
  • NMG 58.09
  • Support Level
  • FBIOP $6.00
  • NMG $1.80
  • Resistance Level
  • FBIOP $6.80
  • NMG $1.99
  • Average True Range (ATR)
  • FBIOP 0.42
  • NMG 0.16
  • MACD
  • FBIOP 0.16
  • NMG 0.04
  • Stochastic Oscillator
  • FBIOP 96.19
  • NMG 68.42

About FBIOP Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Share on Social Networks: